These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 20465373

  • 1. Predictors of attrition from a national sample of methadone maintenance patients.
    Mancino M, Curran G, Han X, Allee E, Humphreys K, Booth BM.
    Am J Drug Alcohol Abuse; 2010 May; 36(3):155-60. PubMed ID: 20465373
    [Abstract] [Full Text] [Related]

  • 2. Predictors of methadone treatment retention from a multi-site study: a survival analysis.
    Kelly SM, O'Grady KE, Mitchell SG, Brown BS, Schwartz RP.
    Drug Alcohol Depend; 2011 Sep 01; 117(2-3):170-5. PubMed ID: 21310552
    [Abstract] [Full Text] [Related]

  • 3. Fiscal strain and access to opiate substitution therapy at Department of Veterans Affairs Medical Centers.
    Rosenheck R, Leslie D, Woody G.
    Am J Addict; 2003 Sep 01; 12(3):220-8. PubMed ID: 12851018
    [Abstract] [Full Text] [Related]

  • 4. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR, Lundahl LH, Ledgerwood DM, Lisieski M, Rhodes GL, Greenwald MK.
    J Subst Abuse Treat; 2015 Jul 01; 54():37-43. PubMed ID: 25795601
    [Abstract] [Full Text] [Related]

  • 5. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
    Trafton JA, Tracy SW, Oliva EM, Humphreys K.
    J Stud Alcohol Drugs; 2007 Mar 01; 68(2):165-72. PubMed ID: 17286334
    [Abstract] [Full Text] [Related]

  • 6. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S.
    J Addict Dis; 2008 Mar 01; 27(3):37-48. PubMed ID: 18956528
    [Abstract] [Full Text] [Related]

  • 7. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E, Schreiber S, Adelson M.
    Drug Alcohol Depend; 2010 Mar 01; 107(2-3):141-8. PubMed ID: 19914783
    [Abstract] [Full Text] [Related]

  • 8. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL, Campbell MD, Spencer RD, Hoffman HA, Crissman B, DuPont RL.
    J Psychoactive Drugs; 2014 Mar 01; 46(2):114-22. PubMed ID: 25052787
    [Abstract] [Full Text] [Related]

  • 9. [Psychiatric disorders associated with high-dose methadone (>100 mg/d): a retrospective analysis of treated patients].
    Eiden C, Leglise Y, Clarivet B, Blayac JP, Peyrière H.
    Therapie; 2012 Mar 01; 67(3):223-30. PubMed ID: 22874488
    [Abstract] [Full Text] [Related]

  • 10. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ, Brown S, Greenwald MK, Ledgerwood DM.
    Subst Abus; 2019 Mar 01; 40(2):185-193. PubMed ID: 30888262
    [Abstract] [Full Text] [Related]

  • 11. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May 01; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 12. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence.
    Strike CJ, Gnam W, Urbanoski K, Fischer B, Marsh DC, Millson M.
    Addict Behav; 2005 Jun 01; 30(5):1025-8. PubMed ID: 15893099
    [Abstract] [Full Text] [Related]

  • 13. Predictors of retention in methadone programs: a signal detection analysis.
    Villafranca SW, McKellar JD, Trafton JA, Humphreys K.
    Drug Alcohol Depend; 2006 Jul 27; 83(3):218-24. PubMed ID: 16384657
    [Abstract] [Full Text] [Related]

  • 14. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone.
    Lister JJ, Greenwald MK, Ledgerwood DM.
    J Subst Abuse Treat; 2017 Jul 27; 78():15-21. PubMed ID: 28554598
    [Abstract] [Full Text] [Related]

  • 15. Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.
    Brooner RK, Kidorf MS, King VL, Peirce J, Neufeld K, Stoller K, Kolodner K.
    Addiction; 2013 Nov 27; 108(11):1942-51. PubMed ID: 23734943
    [Abstract] [Full Text] [Related]

  • 16. Psychiatric services and prescription fills among veterans with serious mental illness in methadone maintenance treatment.
    Marienfeld C, Rosenheck RA.
    J Dual Diagn; 2015 Nov 27; 11(2):128-35. PubMed ID: 25781867
    [Abstract] [Full Text] [Related]

  • 17. Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.
    Zhou K, Zhuang G.
    Addict Behav; 2014 Jan 27; 39(1):22-9. PubMed ID: 24090627
    [Abstract] [Full Text] [Related]

  • 18. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients.
    Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD.
    Drug Alcohol Depend; 2001 Feb 01; 61(3):271-80. PubMed ID: 11164691
    [Abstract] [Full Text] [Related]

  • 19. Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999-2008.
    Rosca P, Haklai Z, Goldberger N, Zohar P, Margolis A, Ponizovsky AM.
    Drug Alcohol Depend; 2012 Sep 01; 125(1-2):160-3. PubMed ID: 22483811
    [Abstract] [Full Text] [Related]

  • 20. Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study.
    Luo C, Sanger N, Zielinski L, Bhatt M, Shahid H, Shams I, Mouravska N, Luetam S, Hudson J, Thabane L, Samaan Z.
    Harm Reduct J; 2019 Feb 11; 16(1):13. PubMed ID: 30744638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.